148 studies found for:    "Arthritis, Juvenile Rheumatoid"
Show Display Options
Rank Status Study
21 Terminated
Has Results
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab;   Drug: Placebo
22 Recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
23 Terminated Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Intervention: Drug: Infliximab
24 Recruiting Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Genetic: Blood test
25 Unknown  Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
26 Completed Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Device: Galileo (whole body vibration (WBV) therapy)
27 Completed An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: Canakinumab
28 Completed BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
29 Unknown  Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Infliximab plus methotrexate;   Drug: Combination of DMARDs;   Drug: Methotrexate alone
30 Completed
Has Results
Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Intervention: Biological: Adalimumab
31 Completed A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Naproxen
32 Completed Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
Condition: Systemic-Onset Juvenile Idiopathic Arthritis
Interventions: Drug: Anakinra;   Biological: Pneumo23
33 Recruiting Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients
Conditions: Rheumatoid Arthritis;   Juvenile Idiopathic Arthritis
Intervention: Procedure: Sampling of blood
34 Withdrawn An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab - Cohort 1;   Drug: Canakinumab - Cohort 2
35 Completed
Has Results
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: canakinumab;   Drug: placebo
36 Unknown  Juvenile Rheumatoid Arthritis Research Registry
Condition: Juvenile Rheumatoid Arthritis
Intervention:
37 Completed
Has Results
Jointstrong Intervention for Juvenile Arthritis
Condition: Juvenile Arthritis
Interventions: Behavioral: CD-ROM;   Behavioral: Wait-list Control Group
38 Completed Juvenile Rheumatoid Arthritis
Condition: Juvenile Chronic Arthritis
Interventions: Drug: Anakinra;   Drug: Placebo
39 Unknown  The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
Conditions: Uveitis;   Arthritis, Juvenile Rheumatoid
Intervention: Drug: TNFR:Fc
40 Recruiting Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis;   Temporomandibular Arthritis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years